Overview

Sublingual Misoprostol to Reduce Blood Loss During Elective Cesarean Delivery

Status:
Unknown status
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
Sublingual Misoprostol to Reduce Blood Loss During Elective Cesarean Delivery : A Randomized Controlled Trial
Phase:
Phase 2
Details
Lead Sponsor:
Ain Shams Maternity Hospital
Treatments:
Misoprostol
Ranitidine
Ranitidine bismuth citrate